Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$16.45 - $25.88 $192,613 - $303,028
11,709 Added 1588.74%
12,446 $226,000
Q3 2020

Nov 16, 2020

SELL
$11.25 - $14.75 $38,655 - $50,681
-3,436 Reduced 82.34%
737 $10,000
Q2 2020

Aug 14, 2020

SELL
$10.69 - $16.49 $568,376 - $876,756
-53,169 Reduced 92.72%
4,173 $47,000
Q1 2020

May 15, 2020

BUY
$9.78 - $29.53 $557,733 - $1.68 Million
57,028 Added 18161.78%
57,342 $821,000
Q2 2019

Aug 14, 2019

SELL
$22.67 - $35.0 $114,574 - $176,890
-5,054 Reduced 94.15%
314 $9,000
Q1 2019

May 15, 2019

SELL
$26.93 - $34.7 $638,752 - $823,049
-23,719 Reduced 81.55%
5,368 $178,000
Q4 2018

Feb 14, 2019

BUY
$27.23 - $45.56 $588,276 - $984,278
21,604 Added 288.71%
29,087 $846,000
Q3 2018

Nov 14, 2018

SELL
$37.57 - $50.34 $301,912 - $404,532
-8,036 Reduced 51.78%
7,483 $344,000
Q2 2018

Aug 14, 2018

BUY
$27.75 - $40.17 $430,652 - $623,398
15,519 New
15,519 $580,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.24B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.